Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Floquet

Showing results (11-20 of 96) with videos related to

Pageof 10
Sort By:
Therapeutic Advances in Medical Oncology|March 14, 2020
How and when to refer patients for oncogenetic counseling in the era of PARP inhibitorsZoé Neviere, Thibault De La Motte Rouge, Anne Floquet, et al.
Bulletin Du Cancer|June 20, 2017
Anne Floquet, Dominique Berton-Rigaud, Gwenael Ferron, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|August 13, 2011
Optimal timing of interval debulking surgery in advanced ovarian cancer: yet to be defined?Eberhard Stoeckle, Benjamin Boubli, Anne Floquet, et al.
Oncology|November 27, 2009
First-line capecitabine monotherapy for slowly progressing metastatic breast cancer: do we need aggressive treatment?Marc Debled, Nicolas Madranges, Alexandra Trainaud, et al.
Brachytherapy|July 25, 2013
Pulsed-dose-rate brachytherapy for uterine cervix carcinoma: 10 years of experience with 226 patients at a single institutionAdeline Petit, Anne Floquet, Olivier Lasbareilles, et al.
Bulletin Du Cancer|February 22, 2014
[Hereditary ovarian carcinomas: clinico-biological features and treatment]Anne Floquet, Eberhard Stoeckle, Sabrina Croce, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 30, 2021
BIOPSAR study: ultrasound-guided pre-operative biopsy to assess histology of sarcoma-suspicious uterine tumors: a new study protocolStamatios Petousis, Sabrina Croce, Michel Kind, et al.
Diagnostic and Interventional Imaging|June 11, 2021
Diffusion-weighted MRI and PET/CT reproducibility in epithelial ovarian cancers during neoadjuvant chemotherapyAmandine Crombé, Lisa Gauquelin, Stéphanie Nougaret, et al.
Plos One|July 7, 2012
MED12 alterations in both human benign and malignant uterine soft tissue tumorsGaëlle Pérot, Sabrina Croce, Agnès Ribeiro, et al.
Investigational New Drugs|November 6, 2004
A phase II study of sabarubicin (MEN-10755) as second line therapy in patients with locally advanced or metastatic platinum/taxane resistant ovarian cancerFrancesco Caponigro, Pax Willemse, Roberto Sorio, et al.
Pageof 10

Showing results (11-20 of 96) with videos related to

Sort By:
Pageof 10
Therapeutic Advances in Medical Oncology|March 14, 2020
How and when to refer patients for oncogenetic counseling in the era of PARP inhibitorsZoé Neviere, Thibault De La Motte Rouge, Anne Floquet, et al.
Bulletin Du Cancer|June 20, 2017
Anne Floquet, Dominique Berton-Rigaud, Gwenael Ferron, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|August 13, 2011
Optimal timing of interval debulking surgery in advanced ovarian cancer: yet to be defined?Eberhard Stoeckle, Benjamin Boubli, Anne Floquet, et al.
Oncology|November 27, 2009
First-line capecitabine monotherapy for slowly progressing metastatic breast cancer: do we need aggressive treatment?Marc Debled, Nicolas Madranges, Alexandra Trainaud, et al.
Brachytherapy|July 25, 2013
Pulsed-dose-rate brachytherapy for uterine cervix carcinoma: 10 years of experience with 226 patients at a single institutionAdeline Petit, Anne Floquet, Olivier Lasbareilles, et al.
Bulletin Du Cancer|February 22, 2014
[Hereditary ovarian carcinomas: clinico-biological features and treatment]Anne Floquet, Eberhard Stoeckle, Sabrina Croce, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 30, 2021
BIOPSAR study: ultrasound-guided pre-operative biopsy to assess histology of sarcoma-suspicious uterine tumors: a new study protocolStamatios Petousis, Sabrina Croce, Michel Kind, et al.
Diagnostic and Interventional Imaging|June 11, 2021
Diffusion-weighted MRI and PET/CT reproducibility in epithelial ovarian cancers during neoadjuvant chemotherapyAmandine Crombé, Lisa Gauquelin, Stéphanie Nougaret, et al.
Plos One|July 7, 2012
MED12 alterations in both human benign and malignant uterine soft tissue tumorsGaëlle Pérot, Sabrina Croce, Agnès Ribeiro, et al.
Investigational New Drugs|November 6, 2004
A phase II study of sabarubicin (MEN-10755) as second line therapy in patients with locally advanced or metastatic platinum/taxane resistant ovarian cancerFrancesco Caponigro, Pax Willemse, Roberto Sorio, et al.
Pageof 10